Displaying 1 - 20 of 195
Centerbridge Seaport Acquisition Fund/BrightSpring Health Services, Inc.
The Federal Trade Commission took action to protect Americans with intellectual and developmental disabilities and their families by requiring Sevita Health (Sevita) to divest more than 100 healthcare facilities to resolve antitrust concerns surrounding its proposed $835 million acquisition of BrightSpring Health Services, Inc.’s (BrightSpring) community living business.
Under the FTC’s proposed consent order, Sevita will be required to divest 128 intermediate care facilities (ICFs), which provide IDD services, and other assets such as day-training programs. The divested facilities—which are in Indiana, Louisiana, and Texas—will be acquired by Dungarvin Group, Inc. (Dungarvin), an experienced and well-regarded operator of ICFs.
On June 10, 2026, the FTC finalized the consent order in this matter.
FTC Requires Divestiture of Ambulatory Surgery Centers to Protect Patients from Anticompetitive Effects of Ascension Health-AmSurg Deal
Ascension/AMSURG, In the Matter of
The Federal Trade Commission took action to protect American patients from higher outpatient surgery costs by requiring national nonprofit health system Ascension Health Alliance (Ascension) to divest several surgery center facilities to complete its proposed $3.9 billion acquisition of AmSurg LLC.
Mercury Marketing LLC, FTC v.
The FTC filed a complaint alleging that Mercury Marketing, LLC, and other defendants impersonated substance use disorder treatment clinics in Google search ads to deceptively route consumers trying to call those clinics to defendant clinics.
Sevita and BrightSpring; Analysis of Proposed Agreement Containing Consent Orders To Aid Public Comment
FTC Takes Action to Prevent Anticompetitive Healthcare Services Merger
FTC and DOJ Host Listening Session on Lowering Americans’ Drug Prices Through Competition
FTC and DOJ Host Listening Session on Lowering Americans’ Drug Prices Through Competition
FTC and DOJ to Host Listening Sessions on Lowering Americans’ Drug Prices Through Competition
Contact Lens Rule Warning Letter Template
Welsh, Carson, Anderson & Stowe, In the Matter of
Welsh, Carson, Anderson & Stowe; Analysis of Agreement Containing Consent Order To Aid Public Comment
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
FTC Sends More Than $1.1 Million in Refunds to Consumers Deceived by Bait-and-Switch Ads for LASIK Vision Correction Procedures
LCA-Vision Inc. d/b/a LasikPlus
In January 2023, the FTC issued an order requiring Ohio-based LCA-Vision, doing business as LasikPlus and Joffe MediCenter, to pay $1.25 million for using deceptive bait-and-switch advertising to trick consumers into believing they could have their vision corrected for less than $300. The order also bans the defendants from making the misrepresentations detailed in the complaint. The Commission approved the final consent order in March 2023. In October 2024, the FTC announced it was returning $1.1 million to defrauded consumers.